LENZ Therapeutics (LENZ) Other financing activities (2021 - 2026)
LENZ Therapeutics' (LENZ) quarterly Other financing activities came in at $14000.0 in Q1 2026, down 68.18% year-on-year from $44000.0 in Q1 2025, and down 97.84% on a QoQ basis from $648000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Other financing activities (2021 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 6 years of Other financing activities data on file, last reported at $14000.0 in Q1 2026.
- On a quarterly basis, Other financing activities fell 68.18% year-over-year to $14000.0 in Q1 2026; TTM through Mar 2026 was $843000.0, a 76.92% decrease from a year earlier, with the FY2025 full-year figure at $873000.0, down 78.38% from the prior year.
- Other financing activities for Q1 2026 stood at $14000.0, down from $648000.0 in the prior quarter.
- Over the last five years, Other financing activities for LENZ reached as high as $4.0 million in Q4 2024 and fell as low as -$3.8 million in Q3 2024.
- Historically, Other financing activities has averaged $447500.0 across 5 years, with a median of $199500.0 in 2023.
- Across the five-year window, Other financing activities surged 9014.29% in 2022 and plunged 94.26% in 2025, its largest moves.
- Year by year, Other financing activities stood at $638000.0 in 2022, then slumped by 68.18% to $203000.0 in 2023, then soared by 1889.16% to $4.0 million in 2024, then slumped by 83.95% to $648000.0 in 2025, then tumbled by 97.84% to $14000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $14000.0 in Q1 2026, $648000.0 in Q4 2025, and -$15000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,000.00 |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 648,000.00 |
| Dec 31, 2025 | 648,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Jun 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 196,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 4.04 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 430,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Mar 31, 2023 | 203,000.00 |